204 related articles for article (PubMed ID: 6143760)
1. Inotropic drugs in the treatment of heart failure.
Scholz H
Hosp Pract (Off Ed); 1984 May; 19(5):57-67, 70-1. PubMed ID: 6143760
[No Abstract] [Full Text] [Related]
2. [Positive inotropic therapy of cardiac failure: old and new drugs, controversies and tests].
Sfrisi C; Cocco G
Clin Ter; 1984 Oct; 111(2):159-67. PubMed ID: 6239739
[No Abstract] [Full Text] [Related]
3. [New drugs with positive inotropic action].
Bijak A; Czołpiński T
Kardiol Pol; 1982; 25(4):357-65. PubMed ID: 6128439
[No Abstract] [Full Text] [Related]
4. [New inotropic drugs].
Ferrari M; Cargnelli G; Piovan D; Bova S; Padrini R
G Ital Cardiol; 1982; 12(2):139-46. PubMed ID: 6293904
[No Abstract] [Full Text] [Related]
5. [Old and new positive inotropic drugs: problems and controversies].
Cocco G; Strozzi C; Tasini MT; Padula A; Urso L; Rizzo A; Alfiero R
Minerva Cardioangiol; 1984 Nov; 32(11):831-42. PubMed ID: 6152331
[No Abstract] [Full Text] [Related]
6. The new inotropic phosphodiesterase inhibitors.
el Allaf D; D'Orio V; Carlier J
Arch Int Physiol Biochim; 1984 Nov; 92(4):S69-79. PubMed ID: 6085243
[TBL] [Abstract][Full Text] [Related]
7. Some new positive inotropic agents.
Andersson KE
Acta Med Scand Suppl; 1986; 707():65-73. PubMed ID: 2874692
[TBL] [Abstract][Full Text] [Related]
8. [Positive inotropic agents. Generalities and classification].
Vahanian A; Le Potier J; Sergent J; Michel PL; Acar J
Ann Med Interne (Paris); 1985; 136(3):242-6. PubMed ID: 2862822
[TBL] [Abstract][Full Text] [Related]
9. Inotropic drugs for treatment of the failing heart.
Maskin CS; Le Jemtel TH; Sonnenblick EH
Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
[No Abstract] [Full Text] [Related]
10. Review: therapeutic concepts of congestive heart failure.
Haustein KO
Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):273-81. PubMed ID: 1974888
[TBL] [Abstract][Full Text] [Related]
11. Inotropic drugs and their mechanisms of action.
Scholz H
J Am Coll Cardiol; 1984 Aug; 4(2):389-97. PubMed ID: 6330195
[TBL] [Abstract][Full Text] [Related]
12. Effects of amrinone on myocardial energetics in severe congestive heart failure.
Baim DS
Am J Cardiol; 1985 Jul; 56(3):16B-18B. PubMed ID: 3161318
[TBL] [Abstract][Full Text] [Related]
13. Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy.
Bassett AL; Gaide MS; Lodge NJ; Cameron JS
Adv Myocardiol; 1985; 6():629-36. PubMed ID: 2986264
[TBL] [Abstract][Full Text] [Related]
14. Intravenous use of amrinone for the treatment of the failing heart.
Mancini D; LeJemtel T; Sonnenblick E
Am J Cardiol; 1985 Jul; 56(3):8B-15B. PubMed ID: 2411122
[TBL] [Abstract][Full Text] [Related]
15. Alternatives to the digitalis glycosides for heart failure.
Johnston GD
Br Med J (Clin Res Ed); 1985 Mar; 290(6471):803-4. PubMed ID: 2858242
[No Abstract] [Full Text] [Related]
16. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure.
Robinson PJ; Lvoff R; Chong B; Barrett PA
Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of positive inotropic phosphodiesterase III inhibitors.
Honerjäger P
Eur Heart J; 1989 Aug; 10 Suppl C():25-31. PubMed ID: 2553411
[TBL] [Abstract][Full Text] [Related]
18. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
Colucci WS; Wright RF; Braunwald E
N Engl J Med; 1986 Feb; 314(6):349-58. PubMed ID: 2418353
[No Abstract] [Full Text] [Related]
19. [Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation].
Kabela E; Michaels DC; Felice EL
Arch Inst Cardiol Mex; 1979; 49(5):892-907. PubMed ID: 398199
[No Abstract] [Full Text] [Related]
20. [Amrinone, a new cardiotonic agent].
Taira N
Nihon Rinsho; 1983 Dec; 41(12):2691-7. PubMed ID: 6371299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
